COMPLETE TEST BANK
Abrams' Clinical Drug Therapy: Rationales for Nursing Practice Thirteenth,
North American Edition by Geralyn Frandsen EdD RN SANDRA PENNINGTON
|| VERIFIED ANSWERS
13TH EDITION
,TABLE OF CONTENTS
SECTION 1: THE CONCEPTUAL FRAMEWORK OF PHARMACOLOGY ................5
CHAPTER 1: THE FOUNDATION OF PHARMACOLOGY: QUALITY AND SAFETY ........................................ 5
CHAPTER 2: BASIC CONCEPTS AND PROCESSES..................................................................................... 14
CHAPTER 3: MEDICATION ADMINISTRATION AND THE NURSING PROCESS OF DRUG THERAPY ......... 22
SECTION 2: DRUG THERAPY THROUGHOUT THE LIFESPAN ......................... 32
CHAPTER 4: PHARMACOLOGY AND THE CARE OF INFANTS AND PEDIATRIC PATIENTS MEDICATION
ADMINISTRATION IN PEDIATRICS ........................................................................................................... 32
CHAPTER 5: PHARMACOLOGY AND THE CARE OF ADULTS AND GERIATRIC PATIENTS......................... 41
CHAPTER 6: PHARMACOLOGY AND THE CARE OF PREGNANT OR LACTATING WOMAN ...................... 49
CHAPTER 7: PHARMACOLOGY AND WOMEN'S HEALTH ........................................................................ 57
CHAPTER 8: PHARMACOLOGY AND MEN'S HEALTH ............................................................................... 57
SECTION 3: DRUGS AFFECTING THE HEMATOPOIETIC AND IMMUNE
SYSTEMS ......................................................................................................... 57
CHAPTER 9: DRUG THERAPY FOR COAGULATION DISORDERS .............................................................. 57
CHAPTER 10: DRUG THERAPY FOR DYSLIPIDEMIA................................................................................. 66
CHAPTER 11: DRUG THERAPY FOR HEMATOPOIETIC DISORDERS ......................................................... 74
CHAPTER 12: DRUG THERAPY: IMMUNIZATIONS .................................................................................. 83
CHAPTER 13: DRUG THERAPY TO DECREASE IMMUNITY ...................................................................... 91
CHAPTER 14: DRUG THERAPY FOR THE TREATMENT OF CANCER ......................................................... 99
SECTION 4: DRUGS AFFECTING INFLAMMATION AND INFECTION .............. 108
CHAPTER 15: INFLAMMATION, INFECTION, AND THE USE OF ANTIMICROBIAL AGENTS ................... 108
CHAPTER 16: DRUG THERAPY TO DECREASE PAIN, FEVER, AND INFLAMMATION ............................. 117
CHAPTER 17: DRUG THERAPY WITH CORTICOSTEROIDS ..................................................................... 125
CHAPTER 18: DRUG THERAPY WITH BETA-LACTAM ANTIBACTERIAL AGENTS.................................... 134
CHAPTER 19: DRUG THERAPY WITH AMINOGLYCOSIDES AND FLUOROQUINOLONES ....................... 143
CHAPTER 20: DRUG THERAPY WITH TETRACYCLINES, SULFONAMIDES, AND URINARY ANTISEPTICS 150
CHAPTER 21: DRUG THERAPY WITH MACROLIDES AND MISCELLANEOUS ANTI-INFECTIVE AGENTS. 157
CHAPTER 22: DRUG THERAPY FOR TUBERCULOSIS AND MYCOBACTERIUM AVIUM COMPLEX DISEASE
.............................................................................................................................................................. 165
CHAPTER 23: DRUG THERAPY FOR VIRAL INFECTIONS ........................................................................ 174
CHAPTER 24: DRUG THERAPY FOR FUNGAL INFECTIONS ..................................................................... 183
CHAPTER 25: DRUG THERAPY FOR PARASITIC INFECTIONS................................................................. 191
,SECTION 5: DRUG AFFECTING THE CARDIOVASCULAR SYSTEM ................ 199
CHAPTER 26: DRUG THERAPY FOR HYPERTENSION............................................................................. 199
CHAPTER 27: DRUG THERAPY FOR DYSRHYTHMIAS ............................................................................. 207
CHAPTER 28: DRUG THERAPY FOR CORONARY HEART DISEASE ......................................................... 215
CHAPTER 29: DRUG THERAPY FOR SHOCK AND HYPOTENSION .......................................................... 225
CHAPTER 30: DRUG THERAPY FOR HEART FAILURE............................................................................. 233
SECTION 6: DRUGS AFFECTING THE RESPIRATORY SYSTEM ..................... 241
CHAPTER 31: DRUG THERAPY FOR NASAL CONGESTION AND COUGH ............................................... 241
CHAPTER 32: DRUG THERAPY TO DECREASE HISTAMINE EFFECTS AND ALLERGIC RESPONSE ........... 250
CHAPTER 33: DRUG THERAPY FOR ASTHMA AND BRONCHOCONSTRICTION ..................................... 259
SECTION 7: DRUGS AFFECTING THE RENAL AND DIGESTIVE SYSTEMS .... 267
CHAPTER 34: DRUG THERAPY FOR FLUID VOLUME EXCESS ................................................................ 267
CHAPTER 35: NUTRITIONAL SUPPORT PRODUCTS, VITAMINS, AND MINERAL SUPPLEMENTS .......... 275
CHAPTER 36: DRUG THERAPY FOR WEIGHT MANAGEMENT .............................................................. 283
CHAPTER 37: DRUG THERAPY FOR PEPTIC ULCER DISEASE AND HYPERACIDITY ................................ 291
CHAPTER 38: DRUG THERAPY FOR NAUSEA AND VOMITING .............................................................. 299
CHAPTER 39: DRUG THERAPY FOR CONSTIPATION AND ELIMINATION PROBLEMS ........................... 306
CHAPTER 40: DRUG THERAPY FOR DIARRHEA ..................................................................................... 315
SECTION 8: DRUGS AFFECTING THE ENDOCRINE SYSTEM ......................... 323
CHAPTER 41: DRUG THERAPY FOR DIABETES MELLITUS ..................................................................... 323
CHAPTER 42: DRUG THERAPY FOR HYPERTHYROIDISM AND HYPOTHYROIDISM ............................... 332
CHAPTER 43: DRUG THERAPY FOR PITUITARY AND HYPOTHALAMIC DYSFUNCTION ......................... 340
CHAPTER 44: DRUG THERAPY TO REGULATE CALCIUM AND BONE METABOLISM ............................. 348
CHAPTER 45: DRUG THERAPY FOR ADDISON'S DISEASE AND CUSHING'S DISEASE ............................ 356
SECTION 9: DRUGS AFFECTING THE AUTONOMIC AND CENTRAL NERVOUS
SYSTEM.......................................................................................................... 362
CHAPTER 46: PHYSIOLOGY OF THE AUTONOMIC AND CENTRAL NERVOUS SYSTEMS AND INDICATIONS
FOR THE USE OF DRUG THERAPY.......................................................................................................... 362
CHAPTER 47: DRUG THERAPY FOR MYASTHENIA GRAVIS, ALZHEIMER'S DISEASE, AND URINARY
RETENTION............................................................................................................................................ 371
CHAPTER 48: DRUG THERAPY FOR PARKINSON'S DISEASE, URINARY SPASTICITY, AND DISORDERS
REQUIRING ANTICHOLINERGIC DRUG THERAPY................................................................................... 379
CHAPTER 49: DRUG THERAPY WITH OPIOIDS ...................................................................................... 388
, CHAPTER 50: DRUG THERAPY WITH LOCAL ANESTHETICS .................................................................. 396
CHAPTER 51: DRUG THERAPY WITH GENERAL ANESTHETICS ............................................................. 402
CHAPTER 52: DRUG THERAPY FOR MIGRAINES AND OTHER HEADACHES .......................................... 407
CHAPTER 53: DRUG THERAPY FOR SEIZURE DISORDERS AND SPASTICITY .......................................... 414
CHAPTER 54: DRUG THERAPY FOR ANXIETY AND INSOMNIA ............................................................. 422
CHAPTER 55: DRUG THERAPY FOR DEPRESSION AND MOOD STABILIZATION .................................... 431
CHAPTER 56: DRUG THERAPY FOR PSYCHOTIC DISORDERS ................................................................ 440
CHAPTER 57: DRUG THERAPY FOR ATTENTION DEFICIT HYPERACTIVITY DISORDER AND NARCOLEPSY
.............................................................................................................................................................. 448
CHAPTER 58: DRUG THERAPY FOR SUBSTANCE ABUSE DISORDERS ................................................... 456
SECTION 10: DRUGS AFFECTING THE EYE, EAR, AND SKIN ........................ 465
CHAPTER 59: DRUG THERAPY FOR DISORDERS OF THE EYE ................................................................ 465
CHAPTER 60: DRUG THERAPY FOR DISORDERS OF THE EAR ............................................................... 473
CHAPTER 61: DRUG THERAPY FOR DISORDERS OF THE SKIN .............................................................. 480
Abrams' Clinical Drug Therapy: Rationales for Nursing Practice Thirteenth,
North American Edition by Geralyn Frandsen EdD RN SANDRA PENNINGTON
|| VERIFIED ANSWERS
13TH EDITION
,TABLE OF CONTENTS
SECTION 1: THE CONCEPTUAL FRAMEWORK OF PHARMACOLOGY ................5
CHAPTER 1: THE FOUNDATION OF PHARMACOLOGY: QUALITY AND SAFETY ........................................ 5
CHAPTER 2: BASIC CONCEPTS AND PROCESSES..................................................................................... 14
CHAPTER 3: MEDICATION ADMINISTRATION AND THE NURSING PROCESS OF DRUG THERAPY ......... 22
SECTION 2: DRUG THERAPY THROUGHOUT THE LIFESPAN ......................... 32
CHAPTER 4: PHARMACOLOGY AND THE CARE OF INFANTS AND PEDIATRIC PATIENTS MEDICATION
ADMINISTRATION IN PEDIATRICS ........................................................................................................... 32
CHAPTER 5: PHARMACOLOGY AND THE CARE OF ADULTS AND GERIATRIC PATIENTS......................... 41
CHAPTER 6: PHARMACOLOGY AND THE CARE OF PREGNANT OR LACTATING WOMAN ...................... 49
CHAPTER 7: PHARMACOLOGY AND WOMEN'S HEALTH ........................................................................ 57
CHAPTER 8: PHARMACOLOGY AND MEN'S HEALTH ............................................................................... 57
SECTION 3: DRUGS AFFECTING THE HEMATOPOIETIC AND IMMUNE
SYSTEMS ......................................................................................................... 57
CHAPTER 9: DRUG THERAPY FOR COAGULATION DISORDERS .............................................................. 57
CHAPTER 10: DRUG THERAPY FOR DYSLIPIDEMIA................................................................................. 66
CHAPTER 11: DRUG THERAPY FOR HEMATOPOIETIC DISORDERS ......................................................... 74
CHAPTER 12: DRUG THERAPY: IMMUNIZATIONS .................................................................................. 83
CHAPTER 13: DRUG THERAPY TO DECREASE IMMUNITY ...................................................................... 91
CHAPTER 14: DRUG THERAPY FOR THE TREATMENT OF CANCER ......................................................... 99
SECTION 4: DRUGS AFFECTING INFLAMMATION AND INFECTION .............. 108
CHAPTER 15: INFLAMMATION, INFECTION, AND THE USE OF ANTIMICROBIAL AGENTS ................... 108
CHAPTER 16: DRUG THERAPY TO DECREASE PAIN, FEVER, AND INFLAMMATION ............................. 117
CHAPTER 17: DRUG THERAPY WITH CORTICOSTEROIDS ..................................................................... 125
CHAPTER 18: DRUG THERAPY WITH BETA-LACTAM ANTIBACTERIAL AGENTS.................................... 134
CHAPTER 19: DRUG THERAPY WITH AMINOGLYCOSIDES AND FLUOROQUINOLONES ....................... 143
CHAPTER 20: DRUG THERAPY WITH TETRACYCLINES, SULFONAMIDES, AND URINARY ANTISEPTICS 150
CHAPTER 21: DRUG THERAPY WITH MACROLIDES AND MISCELLANEOUS ANTI-INFECTIVE AGENTS. 157
CHAPTER 22: DRUG THERAPY FOR TUBERCULOSIS AND MYCOBACTERIUM AVIUM COMPLEX DISEASE
.............................................................................................................................................................. 165
CHAPTER 23: DRUG THERAPY FOR VIRAL INFECTIONS ........................................................................ 174
CHAPTER 24: DRUG THERAPY FOR FUNGAL INFECTIONS ..................................................................... 183
CHAPTER 25: DRUG THERAPY FOR PARASITIC INFECTIONS................................................................. 191
,SECTION 5: DRUG AFFECTING THE CARDIOVASCULAR SYSTEM ................ 199
CHAPTER 26: DRUG THERAPY FOR HYPERTENSION............................................................................. 199
CHAPTER 27: DRUG THERAPY FOR DYSRHYTHMIAS ............................................................................. 207
CHAPTER 28: DRUG THERAPY FOR CORONARY HEART DISEASE ......................................................... 215
CHAPTER 29: DRUG THERAPY FOR SHOCK AND HYPOTENSION .......................................................... 225
CHAPTER 30: DRUG THERAPY FOR HEART FAILURE............................................................................. 233
SECTION 6: DRUGS AFFECTING THE RESPIRATORY SYSTEM ..................... 241
CHAPTER 31: DRUG THERAPY FOR NASAL CONGESTION AND COUGH ............................................... 241
CHAPTER 32: DRUG THERAPY TO DECREASE HISTAMINE EFFECTS AND ALLERGIC RESPONSE ........... 250
CHAPTER 33: DRUG THERAPY FOR ASTHMA AND BRONCHOCONSTRICTION ..................................... 259
SECTION 7: DRUGS AFFECTING THE RENAL AND DIGESTIVE SYSTEMS .... 267
CHAPTER 34: DRUG THERAPY FOR FLUID VOLUME EXCESS ................................................................ 267
CHAPTER 35: NUTRITIONAL SUPPORT PRODUCTS, VITAMINS, AND MINERAL SUPPLEMENTS .......... 275
CHAPTER 36: DRUG THERAPY FOR WEIGHT MANAGEMENT .............................................................. 283
CHAPTER 37: DRUG THERAPY FOR PEPTIC ULCER DISEASE AND HYPERACIDITY ................................ 291
CHAPTER 38: DRUG THERAPY FOR NAUSEA AND VOMITING .............................................................. 299
CHAPTER 39: DRUG THERAPY FOR CONSTIPATION AND ELIMINATION PROBLEMS ........................... 306
CHAPTER 40: DRUG THERAPY FOR DIARRHEA ..................................................................................... 315
SECTION 8: DRUGS AFFECTING THE ENDOCRINE SYSTEM ......................... 323
CHAPTER 41: DRUG THERAPY FOR DIABETES MELLITUS ..................................................................... 323
CHAPTER 42: DRUG THERAPY FOR HYPERTHYROIDISM AND HYPOTHYROIDISM ............................... 332
CHAPTER 43: DRUG THERAPY FOR PITUITARY AND HYPOTHALAMIC DYSFUNCTION ......................... 340
CHAPTER 44: DRUG THERAPY TO REGULATE CALCIUM AND BONE METABOLISM ............................. 348
CHAPTER 45: DRUG THERAPY FOR ADDISON'S DISEASE AND CUSHING'S DISEASE ............................ 356
SECTION 9: DRUGS AFFECTING THE AUTONOMIC AND CENTRAL NERVOUS
SYSTEM.......................................................................................................... 362
CHAPTER 46: PHYSIOLOGY OF THE AUTONOMIC AND CENTRAL NERVOUS SYSTEMS AND INDICATIONS
FOR THE USE OF DRUG THERAPY.......................................................................................................... 362
CHAPTER 47: DRUG THERAPY FOR MYASTHENIA GRAVIS, ALZHEIMER'S DISEASE, AND URINARY
RETENTION............................................................................................................................................ 371
CHAPTER 48: DRUG THERAPY FOR PARKINSON'S DISEASE, URINARY SPASTICITY, AND DISORDERS
REQUIRING ANTICHOLINERGIC DRUG THERAPY................................................................................... 379
CHAPTER 49: DRUG THERAPY WITH OPIOIDS ...................................................................................... 388
, CHAPTER 50: DRUG THERAPY WITH LOCAL ANESTHETICS .................................................................. 396
CHAPTER 51: DRUG THERAPY WITH GENERAL ANESTHETICS ............................................................. 402
CHAPTER 52: DRUG THERAPY FOR MIGRAINES AND OTHER HEADACHES .......................................... 407
CHAPTER 53: DRUG THERAPY FOR SEIZURE DISORDERS AND SPASTICITY .......................................... 414
CHAPTER 54: DRUG THERAPY FOR ANXIETY AND INSOMNIA ............................................................. 422
CHAPTER 55: DRUG THERAPY FOR DEPRESSION AND MOOD STABILIZATION .................................... 431
CHAPTER 56: DRUG THERAPY FOR PSYCHOTIC DISORDERS ................................................................ 440
CHAPTER 57: DRUG THERAPY FOR ATTENTION DEFICIT HYPERACTIVITY DISORDER AND NARCOLEPSY
.............................................................................................................................................................. 448
CHAPTER 58: DRUG THERAPY FOR SUBSTANCE ABUSE DISORDERS ................................................... 456
SECTION 10: DRUGS AFFECTING THE EYE, EAR, AND SKIN ........................ 465
CHAPTER 59: DRUG THERAPY FOR DISORDERS OF THE EYE ................................................................ 465
CHAPTER 60: DRUG THERAPY FOR DISORDERS OF THE EAR ............................................................... 473
CHAPTER 61: DRUG THERAPY FOR DISORDERS OF THE SKIN .............................................................. 480
